Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases

被引:2
|
作者
Florez, Marcus A. [1 ]
De, Brian [1 ]
Chapman, Bhavana, V [1 ]
Prayongrat, Anussara [1 ]
Thomas, Jonathan G. [2 ]
Beckham, Thomas H. [1 ]
Wang, Chenyang [1 ]
Yeboa, Debra N. [1 ]
Bishop, Andrew J. [1 ]
Briere, Tina [3 ]
Amini, Behrang [4 ]
Li, Jing [1 ]
Tatsui, Claudio E. [2 ]
Rhines, Laurence D. [2 ]
Ghia, Amol J. [1 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Neurol Surg, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Musculoskeletal Imaging, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, 1515 Holcombe Blvd,Unit 1202, Houston, TX 77030 USA
来源
RADIATION ONCOLOGY JOURNAL | 2023年 / 41卷 / 01期
基金
美国国家卫生研究院;
关键词
Radiosurgery; Re-irradiation; Radiotherapy dosage; Local neoplasm recurrence; Neoplasm metastasis; BODY RADIATION-THERAPY; RADIOTHERAPY; RISK; SURVIVAL; TOXICITY; OUTCOMES; FAILURE;
D O I
10.3857/roj.2022.00353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: There has been limited work assessing the use of re-irradiation (re-RT) for local failure fol-lowing stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conven-tionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure. Materials and Methods: We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control following re-RT was defined as the absence of progression at the treated site as determined by magnetic resonance imaging. Results: Competing risk analysis for local failure was performed using a Fine-Gray model. The median follow-up time was 25 months and median overall survival (OS) was 16 months (95% confidence in-terval [CI], 10.8-24.9 months) following cEBRT re-RT. Multivariable Cox proportional-hazards analysis revealed Karnofsky performance score prior to re-RT (hazard ratio [HR] = 0.95; 95% CI, 0.93- 0.98; p = 0.003) and time to local failure (HR = 0.97; 95% CI, 0.94-1.00; p = 0.04) were associated with lon-ger OS, while male sex (HR = 3.92; 95% CI, 1.64-9.33; p = 0.002) was associated with shorter OS. Local control at 12 months was 81% (95% CI, 69.3-94.0). Competing risk multivariable regression revealed radioresistant tumors (subhazard ratio [subHR] = 0.36; 95% CI, 0.15-0.90; p = 0.028) and epidural disease (subHR = 0.31; 95% CI, 0.12-0.78; p =0.013) were associated with increased risk of local failure. At 12 months, 91% of patients maintained ambulatory function. Conclusion: Our data suggest that cEBRT following SSRS local failure can be used safely and effec-tively. Further investigation is needed into optimal patient selection for cEBRT in the retreatment set-ting.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 50 条
  • [41] Patterns of relapse and clinical outcomes following stereotactic re-irradiation for glioblastoma
    Rogers, S.
    Jegestheeswaran, K.
    Lomax, N.
    Alonso, S.
    Lazeroms, T.
    Riesterer, O.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S885 - S886
  • [42] Stereotactic Radiosurgery for the Treatment of Bulky Spine Metastases
    Kowalchuk, Roman
    Waters, Michael
    Richardson, K.
    Spencer, Kelly
    Larner, James
    Kersh, Charles
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : E52 - E52
  • [43] Stereotactic radiosurgery for the treatment of bulky spine metastases
    Kowalchuk, Roman O.
    Waters, Michael R.
    Richardson, K. Martin
    Spencer, Kelly M.
    Larner, James M.
    Sheehan, Jason P.
    McAllister, William H.
    Kersh, C. R.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) : 381 - 388
  • [44] Stereotactic radiosurgery for the treatment of bulky spine metastases
    Roman O. Kowalchuk
    Michael R. Waters
    K. Martin Richardson
    Kelly M. Spencer
    James M. Larner
    Jason P. Sheehan
    William H. McAllister
    C. R. Kersh
    Journal of Neuro-Oncology, 2020, 148 : 381 - 388
  • [45] Stereotactic Radiosurgery for Spine Metastases of Gastrointestinal Origin
    Sandhu, N.
    Benson, K.
    Kumar, K. A., Jr.
    Von Eyben, R.
    Chang, D. T.
    Soltys, S. G.
    Pollom, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E125 - E126
  • [46] Safety and efficacy of bevacizumab as a radiosensitizer in malignant glioma: Stereotactic re-irradiation for recurrences as a pilot for adjuvant treatment
    Gutin, P. H.
    Mohile, N. A.
    Lymberis, S. C.
    Karinu, S.
    Hou, B. L.
    Abrey, L. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S51 - S52
  • [47] Re-irradiation spine stereotactic body radiotherapy following high-dose conventional radiotherapy for metastatic epidural spinal cord compression: a retrospective study
    Koide, Yutaro
    Haimoto, Shoichi
    Shimizu, Hidetoshi
    Aoyama, Takahiro
    Kitagawa, Tomoki
    Shindo, Yurika
    Nagai, Naoya
    Hashimoto, Shingo
    Tachibana, Hiroyuki
    Kodaira, Takeshi
    JAPANESE JOURNAL OF RADIOLOGY, 2024, 42 (06) : 662 - 672
  • [48] RETRACTED: Is fractionated robotic stereotactic body radiosurgery optional salvage treatment for the re-irradiation of locally recurrent nasopharyngeal carcinoma? (Retracted Article)
    Dogan, Ozlem Yetmen
    Yaprak, Gokhan
    Ozyurt, Hazan
    Bicakci, Beyhan Ceylaner
    Demircioglu, Fatih
    Algul, Emriye
    Isik, Naciye
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (01) : 66 - 71
  • [49] Salvage image-guided stereotactic re-irradiation of local recurrence in prostate cancer
    Timon, G.
    Zerini, D.
    Fodor, C.
    Bazzani, F.
    Maucieri, A.
    Ronchi, S.
    Rojas, D. P.
    Volpe, S.
    Vavassori, A.
    Cattani, F.
    Garibaldi, C.
    Comi, S.
    Cambria, R.
    De Cobelli, O.
    Orecchia, R.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S640 - S641
  • [50] Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme
    Torok, J. A.
    Wegner, R. E.
    Mintz, A. H.
    Heron, D. E.
    Burton, S. A.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2011, 10 (03) : 253 - 258